Stephen Basso
Director of Finance/CFO at INNOVIVA, INC.
Stephen Basso active positions
| Companies | Position | Start | End |
|---|---|---|---|
| INNOVIVA, INC. | Director of Finance/CFO | 2023-08-20 | - |
Career history of Stephen Basso
Former positions of Stephen Basso
| Companies | Position | Start | End |
|---|---|---|---|
| INOZYME PHARMA, INC. | Comptroller/Controller/Auditor | 2017-09-30 | 2021-05-13 |
| Director of Finance/CFO | 2017-09-30 | 2021-05-13 | |
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2008-12-31 | 2017-04-30 |
Cybrexa, Inc.
 Cybrexa, Inc. BiotechnologyHealth Technology Cybrexa, Inc. develops molecule DNA repair inhibitors that directly target the tumor microenvironment. It develops and commercializes technologies that enables to improve cancer therapeutics. The company was founded by Per J. Hellsund, F. Kevin Didden, Ranjit S. Bindra, and Peter Glazer in 2016 and is headquartered in New Haven, CT. | Chief Operating Officer | - | - |
| Director of Finance/CFO | - | - |
Training of Stephen Basso
| Providence College | Undergraduate Degree |
| Boston College | Masters Business Admin |
Statistics
International
| United States | 7 |
Operational
| Director of Finance/CFO | 3 |
| Comptroller/Controller/Auditor | 1 |
| Corporate Officer/Principal | 1 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| INOZYME PHARMA, INC. | Health Technology |
| INNOVIVA, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
Cybrexa, Inc.
Cybrexa, Inc. BiotechnologyHealth Technology Cybrexa, Inc. develops molecule DNA repair inhibitors that directly target the tumor microenvironment. It develops and commercializes technologies that enables to improve cancer therapeutics. The company was founded by Per J. Hellsund, F. Kevin Didden, Ranjit S. Bindra, and Peter Glazer in 2016 and is headquartered in New Haven, CT. | Health Technology |
- Stock Market
- Insiders
- Stephen Basso
- Experience
